Drug Profile
MDX H210
Alternative Names: MDX-H210Latest Information Update: 03 May 2007
Price :
$50
*
At a glance
- Originator Medarex
- Class Bispecific antibodies; Monoclonal antibodies
- Mechanism of Action ERBB 2 receptor antagonists; IgG receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer; Prostate cancer